Abstract
Background Persons living with Human Immunodeficiency Virus (PLHIV) are at a higher risk of developing hypertension. Preventive measures can be taken to lower this risk, but it is important for PLHIV to be aware of this risk. However, it is unclear whether PLHIV perceive themselves to be at risk for hypertension, and if they do, it is unknown to what extent they perceive this risk. This information is crucial in designing and implementing appropriate preventive measures for hypertension targeting this high-risk population. Our study aimed to provide evidence on the level of risk perception for hypertension and associated factors among PLHIV in Kamuli District.
Methodology This was a cross-sectional study conducted among 392 adult PLHIV in Kamuli District. The participants were selected using consecutive sampling and pretested structured questionnaires were used to collect data which later analysed in STATA version 15.0. Descriptive analysis was carried out and data was summarized using frequencies and means. Modified Poisson regression was used to determine factors independently associated with low-risk perception for hypertension.
Result More than half, 68.1% (267/392) perceived themselves to be at low-risk for hypertension. Factors associated with low-risk perception were: residing in peri-urban area (APR=1.23; 95%CI: 1.04 −1.46) and urban areas (APR=0.73; 95%CI:0.54-0.99); having low knowledge of hypertension (APR=1.98; 95%CI: 1.55-2.53); low trust for health workers (APR=1.13; 95%CI: 1.01-1.25); having no other NCD (APR=1.38; 95%CI: 1.00-1.89); having no family history of hypertension (APR=1.42; 95%CI: 1.20-1.68); and consumption of sufficient fruits/vegetables (APR=1.13; 95%CI: 1.01-1.27).
Recommendation There is need to implement appropriate health education programs specifically tailored to increasing knowledge and risk perception for hypertension among PLHIV. Health workers can integrate routine risk assessments into HIV care to identify PLHIV who are at very high-risk of developing hypertension and provide them with personalized care. This can influence adoption of hypertension preventive measures.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Authors received no funding for this research work
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Makerere University Higher Degrees Research and Ethics Committee
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
We have attached the utilized data set with no participant identity
